PTPRC and neoplasm: Flow cytometry analysis of MHC-I expression showed a greater proportion of CD45- cells (including tumour cells) positive for expression of MHC-I in both FAK-wt and FAK-/- tumours in response to IFNγ treatment (figure 1K).